Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patients
Sign Up to like & getrecommendations! Published in 2022 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001521
Abstract: Supplemental Digital Content is available in the text. Introduction Receptors on breast cancer cells play a crucial role in the management of patients. Trastuzumab is a widely used drug for the treatment of HER2/neu expressing… read more here.
Keywords: fab nota; trastuzumab fab; fab; breast cancer ... See more keywords